Difficulties in pain management using oxycodone and fentanyl in enzalutamide-treated patients with advanced prostate cancer
Pain treatment in patients with bone metastasized advanced prostate cancer is often challenging. A range of treatment modalities are available to control prostate cancer-specific pain, such as androgen deprivation therapies, taxane-based chemotherapy, radionuclide therapy with radium-223 or palliative radiotherapy. In addition, analgesics are commonly used for direct symptom management.
Source: Journal of Pain and Symptom Management - Category: Palliative Care Authors: Harm Westdorp, Inge M. van Oort, Cornelis Kramers, Evelien JM. Kuip, Winald R. Gerritsen, Kris CP. Vissers Tags: Letter Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Fentanyl | Oxycodone | OxyContin | Pain | Pain Management | Palliative | Palliative Care | Prostate Cancer